AMARYL Tablets 6.0mg Milligram

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Buy It Now

Active ingredient:

GLIMEPIRIDE

Available from:

Sanofi-Aventis Ireland Limited

Dosage:

6.0mg Milligram

Pharmaceutical form:

Tablets

Authorization date:

2000-07-22

Summary of Product characteristics

                                License
IRISH MEDICINES BOARD ACTS 1995 AND 2006
MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007
(S.I. No.540 of 2007)
PA0540/028/005
Case No: 2071509
The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to
sanofi-aventis Ireland Limited
Citywest Business Campus, Dublin 24, Ireland
an authorisation, subject to the provisions of the said Regulations, in respect of the product
Amaryl 6 mg tablet
The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as
may be specified in the said Regulations as listed on the reverse of this document.
This authorisation, unless previously revoked, shall continue in force from 20/02/2010.
Signed on behalf of the Irish Medicines Board this
________________
A person authorised in that behalf by the said Board.
Irish Medicines Board
______________________________________________________________________________________________________________________
Date Printed 21/04/2010
CRN 2071509
page number: 1
Part II
Summary of Product Characteristics
1 NAME OF THE MEDICINAL PRODUCT
Amaryl 6 mg tablet
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 6 mg glimepiride.
Excipients: 
                                
                                Read the complete document
                                
                            

Search alerts related to this product